We are monitoring the impact of COVID-19 on APAC Therapeutic Vaccines Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 59
Share on
Share on

Asia Pacific Therapeutic Vaccines Market Research Report – Segmented By Disease Type (Autoimmune Disease, Cancer, Neurological Disease, Infectious Disease) and Country (India, China, Japan, South Korea, Australia & New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 59
Pages: 139

APAC Therapeutic Vaccines Market Size (2020 to 2025)

The size of the Asia-Pacific Therapeutic Vaccines Market was estimated at USD 532.03 Million in 2020. It is forecasted to worth USD 2672.43 Million by 2025, growing at a CAGR of 38.1% between 2020 to 2025.

Therapeutic vaccines are biologicals that are intended to treat a viral infection by stimulating the immune system. The therapeutic vaccine Market is different from any other product market. Compared to the pharmaceutical market, it is relatively small, although growing at a fast rate. In the pipeline, several approaches are being developed to boost the immune response to various infectious and cancerous cells. There are presently close to 120 new vaccines in the pipeline of various multinational companies across the globe set to hit the market in the next few years.

Coming to the Asian Market, Yisheng Biopharma, in China, has developed a new vaccine for the post-exposure treatment of rabies infection and is set to enter human clinical trials after a six-year collaboration with research institutes worldwide. In India, Bharat Biotech claimed to have achieved a breakthrough in developing a vaccine to fight the deadly Zika virus, which causes serious congenital disabilities in children.

An increase in funding’s from the government for vaccine development, a rise in investments by the major market players, rising prevalence of the disease, technological advancements, initiatives by NGOs are some of the factors that are propelling the market growth. However, massive capital expenditures, stringent regulatory policies, and high costs associated with treatment are few factors inhibiting its growth.

This research report on the APAC Therapeutic Vaccines Market segmented and sub-segmented into the following categories:

By Disease Type: 

  • Autoimmune Disease
  • Cancer
  • Neurological Disease
  • Infectious Disease

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Major companies operating in the Asia Pacific Therapeutic Vaccines Market covered in this report are GlaxoSmithKline, plc, Merck and Company, Bavarian Nordic, CSL Limited, Emergent BioSolutions Inc., Novartis AG, Johnson and Johnson, MedImmune, LLC, Pfizer, Inc., and Sanofi Pasteur.

  1. Introduction

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

  1. Research Methodology

                2.1 Introduction                                                               

                2.2 Analysis Design                                                         

                2.3 Research Phases                                                      

                                2.3.1 Secondary Research                                           

                                2.3.2 Primary Research                                 

                                2.3.3 Econometric Modelling                                      

                                2.3.4 Expert Validation                                  

                2.4 Study Timeline                                                          

  1. Overview

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 New Developments                                                               

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

  1. Market Segmentation

                5.1 By Disease Type                                                       

                                5.1.1 Autoimmune Disease Vaccines                                      

                                5.1.2 Cancer Vaccines                                    

                                                5.1.2.1 Multikine                             

                                                5.1.2.2 PR1 Peptide                        

                                                5.1.2.3 TroVax                  

                                                5.1.2.4 CYT004-MelQbG10                           

                                5.1.3 Neurological Disease Vaccines                                        

                                                5.1.3.1 ACC- 001                               

                                                5.1.3.2 CAD 106                

                                                5.1.3.3 Parkinson's Disease Vaccine                        

                                                5.1.3.4 Alzheimer's Disease                        

                                5.1.4 Infectious Disease Vaccines                                             

                                                5.1.4.1 Hepatitis C                           

                                                5.1.4.2 HIV/AIDS                              

                                                5.1.4.3 Other Infectious Disease                               

  1. Geographical Analysis

                6.1 Introduction                                                               

                6.2 China                                                             

                6.3 India                                                              

                6.4 Japan                                                            

                6.5 South Korea                                                               

  1. Strategic Analysis

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

  1. Market Leaders' Analysis

                8.1 GlaxoSMithKline plc.                                                              

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Strategic Evaluation and Operations                                            

                                8.1.4 Financial analysis                                  

                                8.1.5 Legal issues                                             

                                8.1.6 Recent Developments                                       

                                8.1.7 SWOT analysis                                       

                                8.1.8 Analyst View                                          

                8.2 Merck and Company                                                              

                8.3 Bavarian Nordic                                                        

                8.4 CSL Limited                                                 

                8.5 Emergent Biosolutions Inc.                                                  

                8.6 Novartis AG                                                

                8.7 Johnson and Johnson                                                            

                8.8 MedImmune LLC                                                     

                8.9 Pfizer Inc.                                                    

                8.10 Sanofi Pasteur                                                        

  1. Competitive Landscape

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

  1. Expert Opinions

                10.1 Market Outlook                                                     

                10.2 Investment Opportunities                                                 

     Appendix                                                                           

  1. List of Tables
  2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Therapeutic Vaccines Market, By Region, From 2020 to 2025 (USD Million)
  2. Asia-Pacific Therapeutic Vaccines Market, By Disease Type, From 2020 to 2025 (USD Million)
  3. Asia-Pacific Autoimmune Disease Vaccines Market, By Region, From 2020 to 2025 (USD Million)
  4. Asia-Pacific Cancer Vaccines Market, By Region, From 2020 to 2025 (USD Million)
  5. Asia-Pacific Neurological Disease Vaccines Market, By Region, From 2020 to 2025 (USD Million)
  6. Asia-Pacific Infectious Disease Vaccines Market, By Region, From 2020 to 2025 (USD Million)
  7. Asia-Pacific Cancer Vaccines Market, By Type, From 2020 to 2025 (USD Million)
  8. Asia-Pacific Multikine Market, By Region, From 2020 to 2025 (USD Million)
  9. Asia-Pacific PR1 Peptide Market, By Region, From 2020 to 2025 (USD Million)
  10. Asia-Pacific TroVax Market, By Region, From 2020 to 2025 (USD Million)
  11. Asia-Pacific CYT004-MelQbG10 Market, By Region, From 2020 to 2025 (USD Million)
  12. Asia-Pacific Neurological Disease Vaccines Market, By Type, From 2020 to 2025 (USD Million)
  13. Asia-Pacific ACC- 001 Market, By Region, From 2020 to 2025 (USD Million)
  14. Asia-Pacific CAD 106 Market, By Region, From 2020 to 2025 (USD Million)
  15. Asia-Pacific Parkinson's Vaccine Market, By Region, From 2020 to 2025 (USD Million)
  16. Asia-Pacific Alzheimer's Vaccine Market, By Region, From 2020 to 2025 (USD Million)
  17. Asia-Pacific Infectious Disease Vaccines Market, By Type, From 2020 to 2025 (USD Million)
  18. Asia-Pacific Hepatitis C Vaccines Market, By Region, From 2020 to 2025 (USD Million)
  19. Asia-Pacific HIV/AIDS Vaccines Market, By Region, From 2020 to 2025 (USD Million)
  20. Asia-Pacific Other Infectious Disease Vaccines Market, By Region, From 2020 to 2025 (USD Million)
  21. China Therapeutic Vaccines Market, By Disease Type, From 2020 to 2025 (USD Million)
  22. India Therapeutic Vaccines Market, By Disease Type, From 2020 to 2025 (USD Million)
  23. Japan Therapeutic Vaccines Market, By Disease Type, From 2020 to 2025 (USD Million)
  24. South Korea Therapeutic Vaccines Market, By Disease Type, From 2020 to 2025 (USD Million)
  25. China Cancer Vaccines Market, By Type, From 2020 to 2025 (USD Million)
  26. India Cancer Vaccines Market, By Type, From 2020 to 2025 (USD Million)
  27. Japan Cancer Vaccines Market, By Type, From 2020 to 2025 (USD Million)
  28. South Korea Cancer Vaccines Market, By Type, From 2020 to 2025 (USD Million)
  29. China Neurological Disease Vaccines Market, By Type, From 2020 to 2025 (USD Million)
  30. India Neurological Disease Vaccines Market, By Type, From 2020 to 2025 (USD Million)
  31. Japan Neurological Disease Vaccines Market, By Type, From 2020 to 2025 (USD Million)
  32. South Korea Neurological Disease Vaccines Market, By Type, From 2020 to 2025 (USD Million)
  33. China Infectious Disease Vaccines Market, By Type, From 2020 to 2025 (USD Million)
  34. India Infectious Disease Vaccines Market, By Type, From 2020 to 2025 (USD Million)
  35. Japan Infectious Disease Vaccines Market, By Type, From 2020 to 2025 (USD Million)
  36. South Korea Infectious Disease Vaccines Market, By Type, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample